Zusammenfassung
Die vorliegende Übersichtsarbeit Tumorverdacht konzentriert sich im Wesentlichen auf das maligne duktale Adenokarzinom des Pankreaskopfes. Männer sind von der Erkrankung häufiger betroffen als Frauen (Verhältnis ca. 2:1). Die Inzidenz liegt bei ca. 10–15 Erkrankungsfälle pro 100.000 Einwohner in Deutschland. Die Häufigkeit ist insgesamt steigend. Die einzig potenziell kurative Therapie des Adenokarzinoms des Pankreas ist die chirurgische R0-Resektion. Zurzeit sind jedoch nur ca. 20 % aller Patienten zum Zeitpunkt der Diagnosestellung potenziell kurativ resektabel und auch nach erfolgreicher Resektion ist das Langzeitüberleben über 5 Jahre mit ca. 20 % ernüchternd schlecht. Insgesamt überleben nur 5 % aller Patienten mit der Diagnose Pankreaskarzinom 5 Jahre. Deshalb ist es eine besondere Herausforderung, die Diagnose frühzeitig zu stellen. Gleichzeitig stellt die Differenzialdiagnostik bei Patienten mit vorbestehender chronischer Pankreatitis eine besondere Schwierigkeit der Diagnostik dar, insbesondere weil auch bei diesen Patienten regelmäßig ebenfalls eine Vergrößerung des Pankreaskopfes vorliegt. Eine dritte zentrale Fragestellung ist die nach der chirurgischen Resektabilität. In diesem Beitrag werden die technischen Grundlagen der hauptsächlich genutzten diagnostischen Werkzeuge EUS, CT, MRT und PET/CT beschrieben sowie ihre Vorzüge und Limitationen gegeneinander abgewogen.
Abstract
This review on suspected tumors essentially focuses on malignant ductal adenocarcinoma of the head of the pancreas. Men are more often affected than women (ratio 2:1). The incidence in Germany is approximately 10-15 cases per 100,000 inhabitants and is generally increasing. The only potentially curative therapy for adenocarcinoma of the pancreas is surgical R0 resection; however, currently only approximately 20 % of patients are potentially resectable at the time of diagnosis and even after successful resection the long-term 5-year survival of approximately 20 % is soberingly poor. In total only 5 % of patients with the diagnosis of pancreatic cancer survive longer than 5 years. It is therefore a special challenge to make an early diagnosis. Likewise, the differential diagnosis of patients with pre-existing chronic pancreatitis is a special difficulty in the diagnostics because these patients very often also have an enlarged pancreas head. A third core question is the surgical resectability. This article describes the technical principles of the most commonly used diagnostic tools endoscopic ultrasound (EUS), computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET)/CT and elucidates their advantages and limitations.
Literatur
Bronstein YL, Loyer EM, Kaur H et al (2004) Detection of small pancreatic tumors with multiphasic helical CT. Am J Roentgenol 182: 619–623
Buchs NC, Bühler L, Bucher P et al (2011) Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study. J Gastroenterol Hepatol 26: 657–662
Campisi A, Brancatelli G, Vullierme MP et al (2009) Are pancreatic calcifications specific for the diagnosis of chronic pancreatitis? A multidetector-row CT analysis. Clin Radiol 64: 903–911
De Angelis C, Repici A, Carucci P et al (2007) Pancreatic cancer imaging: the new role of endoscopic ultrasound. JOP 9: 85–97
DeWitt J, Devereaux B, Chriswell M et al (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141: 753–763
Diederichs CG, Staib L, Vogel J et al (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20: 109–116
D’Onofrio M, Barbi E, Dietrich CF et al (2012) Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 81: 630–638
D’Onofrio M, Crosara S, Signorini M et al (2013) Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinoma. Ultraschall Med 34: 377–381
Fletcher JG, Wiersma MJ, Farrell MA et al (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229: 81–90
Francis IR (2007) Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI). Cancer Imaging 7: 160–165
Fukushima H, Itoh S, Takada A et al (2006) Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma. Eur Radiol 16: 1709–1718
Fusari M, Maurea S, Imbriaco M et al (2010) Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses. Radiol Med 115: 453–466
Gerstenmaier JF, Malone DE (2011) Mass lesions in chronic pancreatitis: benign or malignant? An „evidencebased practice“ approach. Abdom Imaging 36: 569–577
Giovannini M, Hookey LC, Bories E et al (2006) Endoscopic ultrasound elastography: the first step towards virtual biopsy? Preliminary results in 49 patients. Endoscopy 38: 344–348
Giovannini M, Thomas B, Erwan B et al (2009) Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J Gastroenterol 15: 1587–1593
Grenacher L, Klauss M (2009) Computed tomography of pancreatic tumors. Radiologe 49: 107–123
Gulik TM van, Moojen TM, Geenen R van et al (1999) Differential diagnosis of focal pancreatitis and pancreatic cancer. Ann Oncol 10 (Suppl 4): 85–88
Heinrich S, Goerres GW, Schäfer M et al (2005) Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 242: 235–243
Hirche TO, Ignee A, Barreiros AP et al (2008) Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 40: 910–917
Hochwald SN, Rofsky NM, Dobryansky M et al (1999) Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma. J Gastrointest Surg 3: 506–511
Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221: 107–116
Irie H, Honda H, Kaneko K et al (1997) Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging 22: 429–433
Janssen J, Schlörer E, Greiner L (2007) EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc 65: 971–978
Kaneko OF, Lee DM, Wong J et al (2010) Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma. J Comput Assist Tomogr 34: 732–738
Kauhanen SP, Komar G, Seppänen MP et al (2009) A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg 250: 957–963
Kim YE, Park MS, Hong HS et al (2009) Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 250: 758–765
Kitano M, Kudo M, Maekawa K et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53: 854–859
Klapman JB, Chang KJ, Lee JG et al (2005) Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol 100: 2658–2661
Klapman J, Malafa MP (2008) Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control 15: 280–287
Klöppel G, Maillet B (1991) Histological typing of pancreatic and periampullary carcinoma. Eur J Surg Oncol 17: 139–152
Koelblinger C, Ba-Ssalamah A, Goetzinger P et al (2011) Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology 259: 757–766
Komanduri S, Keswani R (2011) Feasability, specimen adequacy and diagnostic accuracy of a new EUS guided core biopsy needle: a pilot study. Gastrointest Endosc 73: AB336
Legmann P, Vignaux O, Dousset B et al (1998) Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. Am J Roentgenol 170: 1315–1322
Lowenfels AB, Maisonneuve P, Cavallini G et al (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328: 1433–1437
McNulty NJ, Francis IR, Platt JF et al (2001) Multi-detector row helical CT of the pancreas: effect of contrastenhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220: 97–102
Nishiyama Y, Yamamoto Y, Yokoe K et al (2005) Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann Nucl Med 19: 491–497
Ophir J, Céspedes I, Ponnekanti H et al (1991) Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13: 111–134
Park HS, Lee JM, Choi HK et al (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30: 586–595
Pei Q, Zou X, Zhang X et al (2012) Diagnostic value of EUS elastography in differentiation of benign and malignant solid pancreatic masses: a meta-analysis. Pancreatology 12: 402–408
Piscaglia F, Nolsøe C, Dietrich CF et al (2012) The EFSUMB guidelines and recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33: 33–59
Prokesch RW, Chow LC, Beaulieu CF et al (2002) Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformationsinitial experience. Radiology 225: 759–765
Prokesch RW, Chow LC, Beaulieu CF et al (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224: 764–768
Săftoiu A, Vilmann P (2009) Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound 37: 1–17
Saftoiu A, Vilmann P, Gorunesco F et al (2011) Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy 43: 596–603
Sandrasegaran K, Nutakki K, Tahir B et al (2013) Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer. Am J Roentgenol 201: 1002–1008
Schick V, Franzius C, Beyna T et al (2008) Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging 35: 1775–1785
Seicean A, Badea R, Mocan T et al (2008) Radial endoscopic ultrasonography in the preoperative staging of pancreatic cancer. J Gastrointestin Liver Dis 17: 273–278
Shrikhande SV, Barreto SG, Goel M et al (2012) Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford) 14: 658–668
Shrikhande SV, Arya S, Barreto SG et al (2011) Borderline resectable pancreatic tumors: is there a need for further refinement of this stage? Hepatobiliary Pancreat Dis Int 10: 319–324
Soriano A, Castells A, Ayuso C et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99: 492–501
Strobel K, Heinrich S, Bhure U et al (2008) Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J Nucl Med 49: 1408–1413
Tang S, Huang G, Liu J et al (2011) Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis. Eur J Radiol 78: 142–150
Tamm EP, Loyer EM, Faria SC et al (2007) Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 32: 660–667
Tapper EB, Martin D, Adsay NV et al (2010) An MRI-driven practice: a new perspective on MRI for the evaluation of adenocarcinoma of the head of the pancreas. J Gastrointest Surg 14: 1292–1297
van Kouwen MC, Jansen JB, van Goor H et al (2004) FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 32: 399–404
Vargas R, Nino-Murcia M, Trueblood W et al (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and respectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182: 419–425
Wang Z, Chen JQ, Liu JL et al (2013) FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World J Gastroenterol 19: 4808–4817
Williams DB, Sahai AV, Aabakken L et al (1999) Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 44: 720–726
Xu W, Shi J, Zeng X et al (2011) EUS elastography for the differentiation of benign and malignant lymph nodes: a meta-analysis. Gastrointest Endosc 74: 1001–1009
Yamada Y, Mori H, Matsumoto S et al (2010) Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT. Abdom Imaging 35: 163–171
Zech CJ, Bruns C, Reiser MF et al (2008) Tumor-like lesion of the pancreas in chronic pancreatitis: imaging characteristics of computed tomography. Radiologe 48: 777–784
Zhao WY, Luo M, Sun YW et al (2009) Computed tomography in diagnosing vascular invasion in pancreatic and periampullary cancers: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int 8: 457–464
Einhaltung ethischer Richtlinien
Interessenkonflikt. G. Layer, E.S. Fuchs und J. Hoffend geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Layer, G., Fuchs, E. & Hoffend, J. Moderne Pankreasdiagnostik bei Tumorverdacht. Gastroenterologe 9, 21–30 (2014). https://doi.org/10.1007/s11377-013-0820-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-013-0820-0